• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
A dose-response study of the anticoagulant and lipolytic activities of heparin in normal subjects.正常受试者中肝素抗凝及脂解活性的剂量反应研究。
Br J Clin Pharmacol. 1979 May;7(5):531-3. doi: 10.1111/j.1365-2125.1979.tb01000.x.
2
[Changes in post-heparin liprotein lipase activity after testosterone treatment].[睾酮治疗后肝素后脂蛋白脂肪酶活性的变化]
G Clin Med. 1978 May-Jun;59(5-6):199-209.
3
Lipolytic and anticoagulant activities of a low molecular weight fragment of heparin.肝素低分子量片段的脂解和抗凝活性
Eur J Clin Invest. 1985 Aug;15(4):215-20. doi: 10.1111/j.1365-2362.1985.tb00171.x.
4
[Studies on the determination method of heparin-induced lipoprotein lipase activity in human plasma. II. Normal values of plasma lipoprotein lipase activity and various factors influencing plasma lipoprotein lipase activity (author's transl)].
Rinsho Byori. 1973 Sep;21(9):795-8.
5
Effect of insulin on plasma postheparin lipoprotein lipase activity in patients with coronary sclerosis and in control subjects.胰岛素对冠状动脉硬化患者及对照受试者血浆肝素后脂蛋白脂肪酶活性的影响。
Atherosclerosis. 1973 Sep-Oct;18(2):265-75. doi: 10.1016/0021-9150(73)90105-6.
6
[Plasmatic elimination of lipids and diabetes. Studies of lipoprotein lipase].[血浆脂质清除与糖尿病。脂蛋白脂肪酶的研究]
C R Seances Soc Biol Fil. 1972;166(8):1067-70.
7
Effects of acetylsalicylic acid on plasma lipids and on post-heparin lipase activities.乙酰水杨酸对血脂及肝素后脂肪酶活性的影响。
Int J Clin Pharmacol Ther Toxicol. 1981 Mar;19(3):112-6.
8
Plasma lipoprotein lipase activity in primary type IV hyperlipoproteinaemia.
Scott Med J. 1972 Jun;17(6):214-6. doi: 10.1177/003693307201700604.
9
[Effect of the intravenous administration of homologous albumin on the lipolytic enzyme activity of rabbit blood plasma].
Vopr Med Khim. 1984 Mar-Apr;30(2):87-91.
10
Post-heparin lipolytic activity and blood platelets.肝素后脂解活性与血小板
Nature. 1967 Jul 8;215(5097):163-4. doi: 10.1038/215163a0.

引用本文的文献

1
PET Imaging in Cardiac Sarcoidosis: A Narrative Review with Focus on Novel PET Tracers.心脏结节病的正电子发射断层显像（PET）：聚焦新型PET示踪剂的叙述性综述
Pharmaceuticals (Basel). 2021 Dec 9;14(12):1286. doi: 10.3390/ph14121286.
2
Acquisition, Processing, and Interpretation of PET F-FDG Viability and Inflammation Studies.正电子发射断层扫描 F-FDG 存活和炎症研究的采集、处理和解读。
Curr Cardiol Rep. 2021 Jul 16;23(9):124. doi: 10.1007/s11886-021-01555-7.
3
F-18 fluorodeoxyglucose positron emission tomography/computed tomography in the infection of heart.F-18氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描在心脏感染中的应用
Yeungnam Univ J Med. 2021 Apr;38(2):95-106. doi: 10.12701/yujm.2020.00479. Epub 2020 Oct 15.
4
Characterization of a highly effective preparation for suppression of myocardial glucose utilization.一种高效抑制心肌葡萄糖利用制剂的特性研究。
J Nucl Cardiol. 2020 Jun;27(3):849-861. doi: 10.1007/s12350-019-01786-w. Epub 2019 Jun 24.
5
Recommendations for F-fluorodeoxyglucose positron emission tomography imaging for diagnosis of cardiac sarcoidosis-2018 update: Japanese Society of Nuclear Cardiology recommendations.2018年更新版：日本核心脏病学会关于¹⁸F-氟脱氧葡萄糖正电子发射断层显像用于心脏结节病诊断的建议
J Nucl Cardiol. 2019 Aug;26(4):1414-1433. doi: 10.1007/s12350-019-01755-3.
6
Joint SNMMI-ASNC expert consensus document on the role of F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring.SNMMI-ASNC关于F-FDG PET/CT在心脏结节病检测和治疗监测中作用的联合专家共识文件。
J Nucl Cardiol. 2017 Oct;24(5):1741-1758. doi: 10.1007/s12350-017-0978-9.
7
Joint SNMMI-ASNC Expert Consensus Document on the Role of F-FDG PET/CT in Cardiac Sarcoid Detection and Therapy Monitoring.SNMMI-ASNC关于F-FDG PET/CT在心脏结节病检测和治疗监测中作用的联合专家共识文件。
J Nucl Med. 2017 Aug;58(8):1341-1353. doi: 10.2967/jnumed.117.196287.
8
Optimizing myocardial metabolism for fluorine-18 fluorodeoxyglucose positron emission tomography imaging of cardiac inflammation.优化用于心脏炎症氟-18氟脱氧葡萄糖正电子发射断层显像的心肌代谢。
J Nucl Cardiol. 2018 Aug;25(4):1372-1375. doi: 10.1007/s12350-017-0872-5. Epub 2017 Apr 21.
9
ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures.美国核医学与分子影像学会（ASNC）正电子发射断层扫描（PET）核心脏病学检查的成像指南/SNMMI程序标准。
J Nucl Cardiol. 2016 Oct;23(5):1187-1226. doi: 10.1007/s12350-016-0522-3. Epub 2016 Jul 8.
10
Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography imaging of inflammation.用于炎症的心脏氟-18氟脱氧葡萄糖正电子发射断层显像的患者准备
J Nucl Cardiol. 2017 Feb;24(1):86-99. doi: 10.1007/s12350-016-0502-7. Epub 2016 Jun 8.

本文引用的文献

1
DETERMINATION OF HEPARIN-INDUCED LIPOPROTEIN LIPASE ACTIVITY IN HUMAN PLASMA.人血浆中肝素诱导的脂蛋白脂肪酶活性的测定
Clin Chim Acta. 1964 Nov;10:420-7. doi: 10.1016/0009-8981(64)90171-8.
2
The production of lipolytic activity in the circulation of the hind limb in response to heparin.后肢循环中脂解活性对肝素的反应产物。
Q J Exp Physiol Cogn Med Sci. 1959 Jan;44(1):80-90. doi: 10.1113/expphysiol.1959.sp001378.
3
Lipoprotein-lipase responses to heparin.脂蛋白脂肪酶对肝素的反应。
Br J Surg. 1971 Feb;58(2):147-8. doi: 10.1002/bjs.1800580216.
4
Reversible abnormalities in postheparin lipolytic activity during the late phase of release in diabetes mellitus (postheparin lipolytic activity in diabetes).糖尿病释放后期肝素后脂解活性的可逆性异常（糖尿病中的肝素后脂解活性）
Metabolism. 1975 Oct;24(10):1123-37. doi: 10.1016/0026-0495(75)90149-3.
5
Editorial: Low-dose heparin prophylaxis for postoperative venous thromboembolism.社论：低剂量肝素预防术后静脉血栓栓塞症
N Engl J Med. 1975 Aug 7;293(6):300-2. doi: 10.1056/NEJM197508072930612.
6
Differences in heparin-released lipolytic activity in the superficial and deep veins of the human forearm.人前臂浅静脉和深静脉中肝素释放的脂解活性差异。
Eur J Clin Invest. 1977 Jun;7(3):195-9. doi: 10.1111/j.1365-2362.1977.tb01597.x.
7
Heparin, heparin-activated enzymes and platelets.肝素、肝素激活的酶与血小板。
Haemostasis. 1977;6(1):26-34. doi: 10.1159/000214162.

A dose-response study of the anticoagulant and lipolytic activities of heparin in normal subjects.

作者信息

Asmal A C, Leary W P, Thandroyen F, Botha J, Wattrus S

出版信息

Br J Clin Pharmacol. 1979 May;7(5):531-3. doi: 10.1111/j.1365-2125.1979.tb01000.x.

DOI:10.1111/j.1365-2125.1979.tb01000.x
PMID:475949
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1429583/
Abstract
摘要